Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Radioimmunotherapy for treatment of acute myeloid leukaemia and myelodysplastic syndrome: Conceptual chances
Inga Buchmann
*
, R. G. Meyer, W. Herr, A. Helisch, P. Bartenstein
*
Corresponding author for this work
Clinic of Radiology and Nuclear Medicine
Johannes Gutenberg University Mainz
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Radioimmunotherapy for treatment of acute myeloid leukaemia and myelodysplastic syndrome: Conceptual chances'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Radioimmunotherapy
100%
Myelodysplastic Syndrome
100%
Tumor Cell
40%
Primary Tumor
20%
Recurrence Risk
20%
Conditioning
20%
Radioisotope
20%
Acute Toxicity
20%
Consolidation Chemotherapy
20%
Hematopoietic Stem Cell Transplantation
20%
Myeloablative Conditioning
20%
Antibody Conjugate
20%
Mortality Rate
20%
Disease Free Survival
20%
Antileukemic Agent
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Syndrome
40%
Antileukemic Agent
20%
Acute Toxicity
20%
Radioisotope
20%
Neoplasm
20%
Primary Tumor
20%
Antibody Conjugate
20%
Disease Free Survival
20%